FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
SAGE Therapeutics (NASDAQ: SAGE) reported Q2 EPS of ($0.90), $0.22 worse than the analyst estimate of ($0.68).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.
... More
